Anti-nuclear antibodies (ANA) and dsDNA antibodies were the most prevalent autoantibodies observed in these SLE cohorts as determined by ELISA, which were detected in 100% (95/95) and 82.1% (78/95) of SLE patients, respectively (Table 3). The gene discussed is BTG3; the disease is systemic lupus erythematosus.